# A universal, scale-independent artificial intelligence-based platform for manufacturing high titer bacteriophage preparations for clinical applications

> **NIH NIH N44** · INTRALYTIX, INC. · 2022 · $1,498,045

## Abstract

A universal, scale-independent artificial intelligence-based platform for manufacturing high titer bacteriophage preparations for clinical applications.

## Key facts

- **NIH application ID:** 10671440
- **Project number:** 75N93021C00034-P00005-9999-1
- **Recipient organization:** INTRALYTIX, INC.
- **Principal Investigator:** MEL RUZICKA
- **Activity code:** N44 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $1,498,045
- **Award type:** —
- **Project period:** 2021-08-16 → 2025-08-15

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10671440

## Citation

> US National Institutes of Health, RePORTER application 10671440, A universal, scale-independent artificial intelligence-based platform for manufacturing high titer bacteriophage preparations for clinical applications (75N93021C00034-P00005-9999-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10671440. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*